Fundraising Fox

Deepa Pakianathan

Investor

General Partner at Delphi Ventures

San Francisco Bay Area

Writes $50K – $5M checks

About

Deepa Pakianathan leads all biotech investing while serving as CEO and founder of a stealth oncology company, combining active operator experience, recognized expertise in immuno-oncology ADC design, and high-level policy engagement.

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Stealth Oncology CompanyCEO and co-foundercurrent2023 — present
  2. FreenomeIndependent board membercurrent2021 — present
  3. Delphi VenturesGeneral Partnercurrent2001 — presentSan Francisco Bay Area
  4. Palleon PharmaceuticalsLead Director and Independent board membercurrent2020 — present
  5. Theravance Biopharma US, Inc.Independent Board Membercurrent2020 — presentCommittees: Chair of N&G, Member of Audit and Development and Commercialization
  6. Karyopharm Therapeutics Inc.Independent Board Membercurrent2011 — presentCommittees: Chair of Compensation and member of Audit and Development and Commercialization
  7. Mereo BioPharmaIndependent Board Membercurrent2019 — presentChair of Audit and member of Remuneration committee
  8. Calithera BiosciencesLead Director and Independent Board Member2010 — 2023Lead director, Chair of N&G
  9. J.P. MorganVice President1998 — 2001
  10. Genesis Merchant Group SecuritiesResearch Analyst1997 — 1998San Francisco Bay Area
  11. GenentechPost-doctoral scientist1993 — 1997SSF, CA

Education

  1. Wake Forest UniversityDoctor of Philosophy - PhD, Immunology and Immunoparasitology
  2. Wake Forest UniversityMaster of Science - MS, Immunology

Skills & more

Business StrategyMergers & AcquisitionsVenture CapitalEntrepreneurshipInvestment BankingLife Sciences1Biotechnology1Biotech investor1Public biotech Company board director

From Deepa's professional profile.

Colleagues at Delphi Ventures

Doug Roeder
General Partner at Delphi Ventures

Frequently asked questions

Where does Deepa Pakianathan work?
Deepa Pakianathan is General Partner at Delphi Ventures.
What does Deepa Pakianathan invest in?
Deepa Pakianathan invests in Biotech, Healthtech, Medical Devices.
What check size does Deepa Pakianathan write?
Deepa Pakianathan typically writes checks of $50K – $5M.

Same school

Also attended Wake Forest University66

Andrew McGuirkVenture Fellow at Moneta VenturesEliza CushmanPartner at Congruent VenturesBrett BrohlManaging Partner at Bread And Butter Ventures, LlcMariusz AdamskiGeneral Partner at Ff Venture CapitalGregory BillingtonResearch at Transform Capital ManagementJulia de PetraTalent at Audacious

+ 60 more

Shared employers

Also worked at Palleon Pharmaceuticals4

Katarina PancePrincipal at SR One Capital ManagementLori HuManaging Director at Vertex Ventures HCDr. Jens EcksteinAdvisor at Apollo Health VenturesRoss LeimbergFounder / EIR at 82VS

Also worked at Karyopharm Therapeutics Inc.3

Ari ShamissCo-Founder, Managing General Partner at ALIVE Israel HealthTech FundAnat Haas MizrahiManaging Partner at E44 VenturesSharon ShachamManaging Partner at E44 Ventures

Also worked at J.P. Morgan796

Rishi ModiInvestor at GV (Google Ventures)Akshat GoenkaInvestor at Moonfire VenturesNaseem MoumeneVice President at Northzone, investing across complex and fragmented industries undergoing fundamental shiftsFranklin BiGeneral Partner at Pantera CapitalMegan LightcapPartner, Creator Fund at Slow VenturesNatalie SchmitkeManaging Director Capital Networks at Burda Principal Investments

+ 790 more

Also worked at Genentech95

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 89 more